Friday, 27 March 2009

Terazosina Rubio




Terazosina Rubio may be available in the countries listed below.


Ingredient matches for Terazosina Rubio



Terazosin

Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Terazosina Rubio in the following countries:


  • Spain

International Drug Name Search

Friday, 20 March 2009

Clozapine A




Clozapine A may be available in the countries listed below.


Ingredient matches for Clozapine A



Clozapine

Clozapine is reported as an ingredient of Clozapine A in the following countries:


  • Netherlands

International Drug Name Search

Wednesday, 18 March 2009

Falimint




Falimint may be available in the countries listed below.


Ingredient matches for Falimint



Acetylaminonitropropoxybenzene

Acetylaminonitropropoxybenzene is reported as an ingredient of Falimint in the following countries:


  • Georgia

  • Lithuania

  • Russian Federation

International Drug Name Search

Cifarcaina




Cifarcaina may be available in the countries listed below.


Ingredient matches for Cifarcaina



Lidocaine

Lidocaine hydrochloride monohydrate (a derivative of Lidocaine) is reported as an ingredient of Cifarcaina in the following countries:


  • Venezuela

International Drug Name Search

Sunday, 15 March 2009

Dazolin




Dazolin may be available in the countries listed below.


Ingredient matches for Dazolin



Donepezil

Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Dazolin in the following countries:


  • Chile

Naphazoline

Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Dazolin in the following countries:


  • Argentina

International Drug Name Search

Friday, 13 March 2009

Neo-Dexa




Neo-Dexa may be available in the countries listed below.


Ingredient matches for Neo-Dexa



Dexamethasone

Dexamethasone is reported as an ingredient of Neo-Dexa in the following countries:


  • Vietnam

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Neo-Dexa in the following countries:


  • Vietnam

International Drug Name Search

Friday, 6 March 2009

Dalman AQ




Dalman AQ may be available in the countries listed below.


Ingredient matches for Dalman AQ



Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Dalman AQ in the following countries:


  • Turkey

International Drug Name Search

Sunday, 1 March 2009

Ritalin


See also: Generic Ritalin LA, Generic Ritalin-SR


Ritalin is a brand name of methylphenidate, approved by the FDA in the following formulation(s):


RITALIN (methylphenidate hydrochloride - tablet; oral)



  • Manufacturer: NOVARTIS

    Approved Prior to Jan 1, 1982

    Strength(s): 10MG [AB], 20MG [RLD][AB], 5MG [AB]

Has a generic version of Ritalin been approved?


Yes. The following products are equivalent to Ritalin:


methylphenidate hydrochloride tablet; oral



  • Manufacturer: MALLINCKRODT

    Approval date: November 27, 1998

    Strength(s): 10MG [AB], 20MG [AB], 5MG [AB]


  • Manufacturer: UCB INC

    Approved Prior to Jan 1, 1982

    Strength(s): 10MG [AB], 20MG [AB], 5MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: August 29, 1997

    Strength(s): 10MG [AB], 20MG [AB], 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ritalin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Ritalin.

See also...

  • Ritalin Consumer Information (Drugs.com)
  • Ritalin Consumer Information (Wolters Kluwer)
  • Ritalin Consumer Information (Cerner Multum)
  • Ritalin Advanced Consumer Information (Micromedex)
  • Methylphenidate Consumer Information (Drugs.com)
  • Methylphenidate Consumer Information (Wolters Kluwer)
  • Methylphenidate Chewable Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Methylphenidate Controlled-Release Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Methylphenidate Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Solution Consumer Information (Wolters Kluwer)
  • Methylphenidate System Consumer Information (Wolters Kluwer)
  • Methylphenidate Consumer Information (Cerner Multum)
  • Methylphenidate transdermal Consumer Information (Cerner Multum)
  • Methylphenidate Oral, Transdermal Advanced Consumer Information (Micromedex)
  • Methylphenidate Transdermal Advanced Consumer Information (Micromedex)
  • Methylphenidate Hydrochloride AHFS DI Monographs (ASHP)